Abbott Laboratories (ABT)

84.71
0.29 0.34
NYSE : Health Technology
Prev Close 85.00
Open 84.78
Day Low/High 84.64 / 85.33
52 Wk Low/High 60.32 / 85.36
Volume 4.46M
Avg Volume 5.10M
Exchange NYSE
Shares Outstanding 1.76B
Market Cap 149.85B
EPS 1.30
P/E Ratio 57.78
Div & Yield 1.28 (1.42%)

Latest News

Abbott Launches First-ever Rapid Point-of-Care HbA1c Test To Aid In The Diagnosis Of Diabetes

Abbott Launches First-ever Rapid Point-of-Care HbA1c Test To Aid In The Diagnosis Of Diabetes

- Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation

Weekly Roundup

A quiet week offered a chance to get ready for volatility around the FOMC meeting and G-20 summit later this month.

Abbott Declares 382ⁿᵈ Consecutive Quarterly Dividend

Abbott Declares 382ⁿᵈ Consecutive Quarterly Dividend

ABBOTT PARK, Ill., June 14, 2019 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents per share.

New Survey Shows Millennials Can Help Avoid Blood Shortages

New Survey Shows Millennials Can Help Avoid Blood Shortages

- 45% of blood donations have historically come from people over 50 years old, but that number is declining1

New Data Show Use Of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels In People Living With Type 2 Diabetes

New Data Show Use Of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels In People Living With Type 2 Diabetes

- Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has a positive impact among adults with Type 2 Diabetes who use multiple injections of insulin daily

Weekly Roundup

Markets surge in face of multiple uncertainties.

Two Trades This Afternoon

We'll trim shares of Comcast and use that to finance a purchase in Kohl's.

Trimming a Healthcare Name for a Large Gain

We think Abbott Labs is a terrific company, but the stock already has a big premium and that may limit the potential of future gains.

A Six-Pack of Biotech Best Bets

A Six-Pack of Biotech Best Bets

Ironically, some experts now see biotech as a safe haven as the sector remains unaffected by trade wars and other global headwinds.

Weekly Roundup

Rough week for stocks capped by new front in tariff wars with Mexico.

Weekly Roundup

Stocks falter on realization that trade war between U.S. and China is about more than soybeans.

TRILUMINATE Study Shows Treatment With Abbott's First-of-its-Kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks

TRILUMINATE Study Shows Treatment With Abbott's First-of-its-Kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks

- Late-breaking data for Abbott's investigational clip-based tricuspid heart valve repair system presented at EuroPCR

The Languishing Continues

In this market of haves and have-nots, too many stocks are still languishing and sentiment is sour -- but we're still likely oversold enough to potentially rally this week.

Rally or Selloff?: Cramer's 'Mad Money' Recap (Friday 5/17/19)

Rally or Selloff?: Cramer's 'Mad Money' Recap (Friday 5/17/19)

Jim Cramer says we'll need to pay close attention to retailers' earnings. Here's your game plan for next week.

Arena Pharmaceuticals, DaVita, Merck: 'Mad Money' Lightning Round

Arena Pharmaceuticals, DaVita, Merck: 'Mad Money' Lightning Round

Jim Cramer weighs in on Arena Pharmaceuticals, DaVita, Merck, Abbott Laboratories, IAC Interactive, Yext and more.

Weekly Roundup

Markets' rocky week ends up close to where it began.

Jim Cramer: These 7 True Laggards Have Caught Fire

Jim Cramer: These 7 True Laggards Have Caught Fire

These kinds of stocks are what goes up when there's so little left that hasn't moved that can still be worth buying.

Nearly 9 Out Of 10 College Students With Student Debt Say It's Important To Find A Company That Offers Loan Relief

Nearly 9 Out Of 10 College Students With Student Debt Say It's Important To Find A Company That Offers Loan Relief

- The YouGov-Abbott Student Loan Impact Survey shows 87% of those in college or graduating this year with student debt say finding a company with a student loan benefit is important to them

Abbott Partners With NIH On BRAIN Initiative To Advance Research For Neurological Disorders

Abbott Partners With NIH On BRAIN Initiative To Advance Research For Neurological Disorders

- Partnership with NIH aims to increase understanding and accelerate the application of neurostimulation therapies

Weekly Roundup

Markets face rocky week as trade wars flare up and talks appear to falter.

Sitting Tight, but We Have the Cash

Now that our cash levels are even more flushed than before, we believe we have prudently acted for the uncertainty we face this week.

Continuing Our Cash-Raising Efforts

There is room here to take even more off the table and lock in some of the big gains.

Abbott To Present At UBS Global Healthcare Conference

Abbott To Present At UBS Global Healthcare Conference

ABBOTT PARK, Ill., May 7, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the UBS Global Healthcare Conference on Tuesday, May 21, 2019.

Abbott Launches Next-generation Detection Technology In The U.S. And Europe, Offering A Smarter Approach To 24/7 Heart Monitoring For People With Irregular Heartbeats

Abbott Launches Next-generation Detection Technology In The U.S. And Europe, Offering A Smarter Approach To 24/7 Heart Monitoring For People With Irregular Heartbeats

WORLD'S FIRST SMARTPHONE-COMPATIBLE IMPLANTABLE HEART MONITOR, ABBOTT'S CONFIRM Rx™ ICM OFFERS MORE ACCURATE DETECTION OF HEART RHYTHM DISORDERS

Abbott Receives WHO Prequalification Approval For Breakthrough HIV Point-of-Care Test

Abbott Receives WHO Prequalification Approval For Breakthrough HIV Point-of-Care Test

- WHO Prequalification approval allows Abbott to bring critical technology to more resource-limited settings

Abbott, The U.S. Department Of Defense And TRACK-TBI Partner To Study Point-of-Care Blood Test For Concussions

Abbott, The U.S. Department Of Defense And TRACK-TBI Partner To Study Point-of-Care Blood Test For Concussions

-- Academic, military and healthcare leaders have come together to conduct a scientifically rigorous clinical trial of a blood test in development for the brain

New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events In Adults With No Known Heart Disease

New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events In Adults With No Known Heart Disease

- Research found Abbott's High-Sensitive Troponin-I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors

Weekly Roundup

Heavy earnings week and strong GDP push stocks higher.

TheStreet Quant Rating: B (Buy)